Background illustration for clinical trials search

Paid Clinical Trials Salt Lake City

Discover 1,106 paid clinical trials in Salt Lake City, Utah. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

for
Major Depressive Disorder
Location: Orem UT, Denver CO, Colorado Springs CO,
Sponsor: Syndeio Biosciences, Inc

Sex: All

Age: 18 - 64

Code: NCT06547489

Phase 2, Recruiting
Featured

A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan

for
Solid Tumors Harboring MET Amplification
Location: West Valley City UT, Duarte CA, Beverly Hills CA,
Sponsor: AbbVie

Sex: All

Age: 12+

Code: NCT07196644

Phase 2, Recruiting
Featured

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

for
Non-Small Cell Lung Cancer,
Location: West Valley City UT, Duarte CA, Los Angeles CA,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT05005403

Phase 1, Recruiting
Featured

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations

for
Multiple Myeloma
Location: Salt Lake City UT, Denver CO, Duarte CA, Irvine CA,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06892522

Phase 1, Phase 2, Recruiting

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Ogden UT, Irving TX, Austin TX, San Antonio TX,
Sponsor: Vividion Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06804824

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age

for
Measles, Measles-Mumps-Rubella+Chickenpox Vaccine
Location: Provo UT, Walnut Creek CA, Frisco TX, Houston TX,
Sponsor: GlaxoSmithKline

Sex: All

Age: 1 - 6

Code: NCT07406360

Phase 3, Recruiting

InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS

for
Respiratory Distress Syndrome (Neonatal),
Location: Provo UT, Phoenix AZ, San Diego CA, Madison WI,
Sponsor: ONY

Sex: All

Age: 0

Code: NCT05960929

Phase 3, Recruiting

Effect of Percussive Massage on Skeletal Muscle During Limb Immobilization

for
Massage Therapy, Muscular Atrophy
Location: Provo UT
Sponsor: Brigham Young University

Sex: All

Age: 18 - 50

Code: NCT06053229

Recruiting
New

Heat Therapy During Reduced Physical Activity

for
Physical Inactivity, Vascular Dysfunction,
Location: Provo UT
Sponsor: Brigham Young University

Sex: All

Age: 18+

Code: NCT07847424

Recruiting

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

for
Agitation, Alzheimer Disease
Location: Provo UT, Aurora CO, Chino CA, West Covina CA,
Sponsor: Celgene

Sex: All

Age: 55 - 70+

Code: NCT06808984

Phase 2, Recruiting

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

for
Major Depressive Episode (MDE), Major Depressive Disorder (MDD),
Location: Provo UT, Las Vegas NV, Phoenix AZ, Chino CA,
Sponsor: Tonix Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07621237

Phase 2, Recruiting
New

A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder

for
Depressive Disorder, Major
Location: Provo UT, Phoenix AZ, Valley Village CA, Irvine CA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07775300

Phase 3, Recruiting

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

for
Schizophrenia
Location: Orem UT, Riverside CA, Chino CA, La Habra CA,
Sponsor: Neurocrine Biosciences

Sex: All

Age: 18 - 65

Code: NCT07114874

Phase 3, Recruiting

Accelerated Transcranial Magnetic Stimulation for Post-Traumatic Stress Disorder

for
PTSD - Post Traumatic Stress Disorder
Location: Provo UT
Sponsor: Cognitive FX

Sex: All

Age: 18 - 65

Code: NCT07463703

Recruiting

Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)

for
Major Depressive Disorder
Location: Orem UT, Rancho Cucamonga CA, West Covina CA,
Sponsor: Autobahn Therapeutics, Inc.

Sex: All

Age: 18 - 65

Code: NCT06633016

Phase 2, Recruiting

A Study of Dotinurad Versus Allopurinol in Tophaceous Gout

for
Tophaceous Gout
Location: Ogden UT, North Las Vegas NV, Denver CO, Great Falls MT,
Sponsor: Crystalys Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07089888

Phase 3, Recruiting

A Study of Dotinurad Versus Allopurinol in Participants With Gout

for
Gout
Location: Ogden UT, North Las Vegas NV, Denver CO, Great Falls MT,
Sponsor: Crystalys Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07089875

Phase 3, Recruiting
New

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

for
Atherosclerosis, Cardiovascular Disease, Obesity, Hypertension,
Location: Ogden UT, Las Vegas NV, Glendora CA, Tucson AZ,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07783802

Phase 2, Recruiting

A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)

for
Cataract
Location: Pleasant Grove UT, Grand Junction CO, Chico CA,
Sponsor: Melt Pharmaceuticals

Sex: All

Age: 18 - 65

Code: NCT06383273

Phase 3, Recruiting

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

for
Inflammatory Bowel Diseases, Crohn's Disease
Location: Ogden UT, North Las Vegas NV, Colorado Springs CO,
Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)

Sex: All

Age: 18 - 70+

Code: NCT06226883

Phase 2, Recruiting